Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Project of a new organization of our establishments in France



The development of regulation applicable to homeopathy in France during the last years causes the fall-off in sales of mother tinctures and the progressive reduction of prescribed specific medications.


We were therefore led to present today to the concerned employees and staff representatives, a project of a new organization of our establishments in France. This project will be discussed in the coming weeks.


 


 


Our next update: January 26, 2017 at market close, publication of the sales revenue for the year 2016.

Person responsible for financial information: Christian Boiron

Contact for financial information: Véronique Bouscayrol

Investor relations: +33 (0) 4.78.45.63.43 - e-mail : [email protected]

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at: www.boironfinance.com




Regulated information

News releases under ongoing reporting obligations:

- other releases

Full and original press release in PDF:


https://www.actusnews.com/documents_communiques/ACTUS-0-46422-cp-boiron_151116.pdf


Receive by email the next press releases of the company by registering on
www.actusnews.com, it's free



Source: Actusnews

Boiron S.A. Aktie

31,05 €
1,14 %
Heute erlebt Boiron S.A. einen merklichen Gewinn von 1,14 %.

Like: 0
Teilen

Kommentare